Event Information

2-part CUA Educational Session

Session begins at 19:30

Part 1 - Insights on Early Stage RCC Detection & Emerging Management Strategies

Chair: Ricard Rendon 

Speaker: Daniel Heng

OBJECTIVES
By participating in this learning program, healthcare providers can expect to:

• Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
• Assess recent adjuvant RCC clinical trial data and their impact on current clinical practice
• Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC

Part 2 - PRECISE: Personalized Medicine and Case-Based Education on PARP inhibitors in Prostate Cancer

Chair: Kim Chi 

Speaker: Krista Noonan

OBJECTIVES

By participating in this learning program, healthcare providers can expect to:

• Discuss the importance of genetic testing for their patients with advanced prostate cancer.
• Understand the efficacy and safety data from randomized control trials investigating PARPi in mCRPC
• Apply the practical knowledge gained from real-world, case-based discussion surrounding PARPi use in patients with mCRPC